NeoGenomics, Inc. (NEO)
16.02
-0.52
(-3.14%)
USD |
NASDAQ |
Nov 13, 16:00
16.00
-0.02
(-0.12%)
After-Hours: 19:59
NeoGenomics Enterprise Value : 2.378B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 2.378B |
| November 12, 2026 | 2.445B |
| November 11, 2026 | 2.483B |
| November 10, 2026 | 2.499B |
| November 09, 2026 | 2.582B |
| November 06, 2026 | 2.484B |
| November 05, 2026 | 2.439B |
| November 04, 2026 | 2.524B |
| November 03, 2026 | 2.483B |
| November 02, 2026 | 2.439B |
| October 30, 2026 | 2.554B |
| October 29, 2026 | 2.625B |
| October 28, 2026 | 2.632B |
| October 27, 2026 | 2.539B |
| October 26, 2026 | 2.465B |
| October 23, 2026 | 2.452B |
| October 22, 2026 | 2.426B |
| October 21, 2026 | 2.510B |
| October 20, 2026 | 2.456B |
| October 19, 2026 | 2.430B |
| October 16, 2026 | 2.459B |
| October 15, 2026 | 2.537B |
| October 14, 2026 | 2.489B |
| October 13, 2026 | 2.461B |
| October 12, 2026 | 2.401B |
| Date | Value |
|---|---|
| October 09, 2026 | 2.421B |
| October 08, 2026 | 2.378B |
| October 07, 2026 | 2.372B |
| October 06, 2026 | 2.441B |
| October 05, 2026 | 2.780B |
| October 02, 2026 | 2.694B |
| October 01, 2026 | 2.605B |
| September 30, 2026 | 2.680B |
| September 29, 2026 | 2.700B |
| September 28, 2026 | 2.770B |
| September 25, 2026 | 2.775B |
| September 24, 2026 | 2.805B |
| September 23, 2026 | 2.651B |
| September 22, 2026 | 2.719B |
| September 21, 2026 | 2.786B |
| September 18, 2026 | 2.850B |
| September 17, 2026 | 2.847B |
| September 16, 2026 | 2.726B |
| September 15, 2026 | 2.719B |
| September 14, 2026 | 2.658B |
| September 11, 2026 | 2.518B |
| September 10, 2026 | 2.555B |
| September 09, 2026 | 2.562B |
| September 08, 2026 | 2.549B |
| September 04, 2026 | 2.526B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Quest Diagnostics, Inc. | 34.44B |
| Labcorp Holdings, Inc. | 36.61B |
| OPKO Health, Inc. | 1.321B |
| Psychemedics Corp. | -- |
| First Choice Healthcare Solutions, Inc. | 44.28M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.546M |
| Revenue (Quarterly) | 209.25M |
| Total Expenses (Quarterly) | 216.80M |
| EPS Diluted (Quarterly) | -0.0587 |
| Gross Profit Margin (Quarterly) | 44.72% |
| Profit Margin (Quarterly) | -3.61% |
| Earnings Yield | -1.57% |
| Normalized Earnings Yield | -1.838 |